Journal
BRITISH JOURNAL OF DERMATOLOGY
Volume 173, Issue 2, Pages 544-546Publisher
WILEY-BLACKWELL
DOI: 10.1111/bjd.13748
Keywords
-
Categories
Ask authors/readers for more resources
Basal cell carcinoma (BCC), the most common cancer in the U.S.A., is treated primarily with local excision. In some cases, lesion size, location or extent prevent complete resection. Locally advanced BCC responds to systemic therapy with the Hedgehog pathway inhibitor vismodegib, but withdrawal of treatment may result in disease relapse. Here we present a case of locally advanced auricular BCC treated with induction vismodegib and radiation, resulting in durable local control and an acceptable level of acute toxicity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available